To access this element change to forms mode OFF
Grant Award View - GA289126
Developing Nanoparticle Mediated Gene Transfer for Childhood Dementia
GA ID:
GA289126
Agency:
Department of Health and Aged Care
Approval Date:
21-Oct-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Mar-2025
Value (AUD):
$302,148.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Developing Nanoparticle Mediated Gene Transfer for Childhood Dementia
Purpose:
Mucopolysaccharidosis Type IIIA is an exemplar childhood dementia for which there is no treatment. While advances in gene therapy hold promise, current viral-based methods have technical limitations and restrictive immunological side effects. We aim to utilize synthetic nanoparticles to introduce working copies of the faulty gene to the brain of an MPS IIIA mouse model and correct disease. Successful outcomes will underpin translation to clinical trial in MPS IIIA and related Childhood Dementias
GO ID:
GO Title:
MRFF – PPHRI & EPCDRI – 2022 Effective Treatments and Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2023757
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
Country:
AUSTRALIA